S-adenosylmethionine (SAM) is an essential metabolite that acts as a cofactor for most methylation events in the cell. The N-methyladenosine (mA) methyltransferase METTL16 controls SAM homeostasis by regulating the abundance of SAM synthetase MAT2A mRNA in response to changing intracellular SAM levels. Here we present crystal structures of METTL16 in complex with MAT2A RNA hairpins to uncover critical molecular mechanisms underlying the regulated activity of METTL16. The METTL16-RNA complex structures reveal atomic details of RNA substrates that drive productive methylation by METTL16. In addition, we identify a polypeptide loop in METTL16 near the SAM binding site with an autoregulatory role. We show that mutations that enhance or repress METTL16 activity in vitro correlate with changes in MAT2A mRNA levels in cells. Thus, we demonstrate the structural basis for the specific activity of METTL16 and further suggest the molecular mechanisms by which METTL16 efficiency is tuned to regulate SAM homeostasis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367934 | PMC |
| http://dx.doi.org/10.1016/j.molcel.2018.07.025 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The promoting effect of the POU3F2/METTL16/PFKM cascade on glycolysis and tumorigenesis of hepatocellular carcinoma.
Ann Hepatol
January 2025
Department of Hepato-Biliary-Pancreatic Surgery, the First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang City, 421001, Hunan, China. Electronic address:
Introduction And Objectives: Deregulation of mA methylation, the most prevailing RNA modification, participates in cancer pathogenesis. METTL16, an atypical methyltransferase, functions as a pro-tumorigenic factor in hepatocellular carcinoma (HCC). Here, we explored the action of METTL16 on HCC glycolysis and the associated mechanism.
View Article and Find Full Text PDFMETTL16 suppresses ferroptosis in cholangiocarcinoma by promoting ATF4 via mA modification.
Int J Biol Sci
January 2025
Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Article Synopsis
- N6-methyladenosine (mA) modification is critical for managing ferroptosis-related RNAs, but its role in cholangiocarcinoma (CC) is still unclear.
- Public databases revealed METTL16's overexpression in CC, indicating poor patient prognosis, and it was found to protect cells from ferroptosis by maintaining mitochondrial health and affecting iron and lipid metabolism.
- Mechanistically, METTL16 enhances ATF4 mRNA stability through m6A modification, which helps prevent ferroptosis in CC, suggesting potential therapeutic targets in the condition.
METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism.
Ecotoxicol Environ Saf
December 2024
Jiangsu Province Engineering Research Center of Antibody Drug, NHC Key Laboratory of Antibody Technique, Department of Immunology, Nanjing Medical University, Nanjing, China. Electronic address:
The persistent airway inflammation is the main characteristic of chronic obstructive pulmonary disease (COPD), typically caused by an indoor environment pollution cigarette smoke (CS). METTL16 is an mA methyltransferase that has been proven to be closely associated with the occurrence of various diseases. However, its exact role in smoking-induced COPD remains to be investigated.
View Article and Find Full Text PDFmA-Methylated NUTM2B-AS1 Promotes Hepatocellular Carcinoma Stemness Feature via Epigenetically Activating Transcription.
J Hepatocell Carcinoma
December 2024
Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, Baise, People's Republic of China.
Purpose: Hepatocellular carcinoma (HCC) is one of the most lethal malignancies in the world. Oncofetal proteins are the optimal diagnostic biomarkers and therapeutic targets for HCC. As the most abundant modification in RNA, N-methyladenosine (mA) has been reported to be involved in HCC initiation and progression.
View Article and Find Full Text PDFMETTL16 and YTHDC1 Regulate Spermatogonial Differentiation via m6A.
Cell Prolif
November 2024
State Key Laboratory of Reproductive Medicine and Offspring Health, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing Medical University, Nanjing, China.
Article Synopsis
- Spermatogenesis is a complex process regulated by various factors, including the mRNA modification m6A, which is vital for transcription during sperm development.
- Despite previous studies showing m6A's presence at different spermatogenesis stages, depletion of two specific methyltransferases (Mettl3 and Mettl14) didn't cause visible abnormalities in early sperm stages, pointing towards the role of other methyltransferases.
- The study highlights the importance of METTL16, as its absence leads to smaller testes and disrupted spermatogonial differentiation, similar to the effects seen with the deletion of the m6A reader protein YTHDC1, ultimately resulting in male infertility.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!